Molecular Profiles Ltd., a subsidiary of Columbia Laboratories, Inc., (Nasdaq: CBRX) and Maryland-based Xceleron have announced a collaboration to assist drug developers with improved efficiency during clinical development that will be launched at AAPS in San Diego next week.
31 October, 2014
Sygnature Discovery, the United Kingdom’s largest independent provider of integrated drug discovery resource and expertise, celebrated its 10th anniversary by hosting a symposium on “Aspects of Modern Drug Discovery”. Held at Nottingham’s East Midlands Conference Centre, the symposium welcomed distinguished scientific speakers from around the country to a packed audience of 200 guests.
24 October, 2014
Domainex Ltd. and Auspherix Pty Ltd today announced a collaboration that will progress Auspherix’s novel anti-infective drug discovery programme towards the nomination of a clinical candidate. Auspherix intends to develop much-needed new drugs to fight the increasing problem of antibiotic-resistant bacterial infections, which have been widely reported as one of the most significant threats to patients' safety across the world.*
22 October, 2014
Ximbio aims to change the way reagents are searched, sourced and shared
20 October, 2014
Three ambitious new research programmes, which aim to deliver a step-change in our understanding of disease by using human volunteers in experimental studies, have been funded as part of a £60m investment from the Medical Research Council (MRC).
07 October, 2014